Pedro Perez/LinkedIn
Apr 3, 2026, 17:12
Pedro Perez: Timing Is the Biggest Challenge in Treating DVT
Pedro Perez, Senior Vascular Consultant at Argon Medical Devices, Inc., shared a post on LinkedIn:
“What I’ve learned after years working alongside physicians treating VTE:
The biggest challenge in treating Deep Vein Thrombosis isn’t technology.
It’s timing.
Too often patients arrive after symptoms have been present for days — sometimes weeks — when clot burden has already begun to organize.
When VTE programs work well inside hospitals, three things are usually happening:
- Early identification in the ER or inpatient setting
- Clear referral pathways to interventional specialists
- Collaboration between specialties (IR, vascular surgery, cardiology)
Technology continues to evolve, but systems of care are what ultimately determine outcomes.
The hospitals seeing the best results are those building true VTE programs, not just treating individual cases.”
Stay updated with Hemostasis Today.
-
Nov 20, 2026, 17:27Adam Bryant: Great Science, Valuable Connections and a Wonderful Haematology Community at Blood 2026
-
Nov 20, 2026, 17:25Gurpreet Kaurr: Scientific Discussions, New Perspectives and Inspiration at HAEMATOCON 2026
-
Nov 20, 2026, 17:24Bispecific FVIIIa-Mimetic Antibodies in Haemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Nov 20, 2026, 17:23Khalid Rehman: Psychosocial Burden Among Caregivers of Patients with Beta-Thalassemia Major in Pakistan
-
Nov 20, 2026, 17:20Dhinesh Selvaraju: Caplacizumab Becomes the First FDA-Approved Treatment for Pediatric aTTP
-
Nov 20, 2026, 17:19Paris Margaritis: Presenting Preclinical Data on GENV-HEM at the WFH Workshop
-
Nov 20, 2026, 17:18WFH Opens Public Comment on Draft Guidelines for Hemostatic Agents and Prophylaxis
-
Nov 20, 2026, 17:18Ketan Asawale: Consensus on the Management of Cancer-Associated Thrombosis in India
-
Nov 20, 2026, 17:16Ajay Samkaria: The Evolution of Hemostasis Diagnostics with the ACL TOP 70 Series